PlainRecalls

Bristol-Myers Squibb Company

Compiled from official public sources by the publisher.

5 recalls on record · Latest: Oct 29, 2025

Subscribe to new Bristol-Myers Squibb Company recalls (RSS)

Agency notice ledger

Federal filing book Bristol-Myers Squibb Company LIGHT-BOOK · SINGLE-AGENCY

#2,395 of 14,151 · 5 notices · 0.005% archive

  • BOOK 5 notices
  • RANK #2,395 of 14,151
  • SHARE 0.005% archive
  • AGENCY FDA Drug (5)
  • CAT drugs
  • CATS 1 category
  • LATEST Oct 29, 2025
  • PHOTO A G Specialty Foods I…

Nearest notice-volume peer: A G Specialty Foods Inc (0 notice gap)

Bristol-Myers Squibb Company accounts for about 0.005% of the 104,423-notice archive on 5 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Bristol-Myers Squibb Company sits among 14,151 recalling firms

Bristol-Myers Squibb Company ranks 2,395th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Bristol-Myers Squibb Company vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

5 2395th of 14151 higher than 11,411 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Bristol-Myers Squibb Company in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Bristol-Myers Squibb Company holds about 0.005% of archive notices alongside 5 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Oct 29, 2025

Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton, NJ 08543, NDC 0003-7125-11
FDA Drug Critical Jul 19, 2017

EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc. New York, NY 10017 USA, NDC 0003-0894-21
FDA Drug Moderate Oct 31, 2012

Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sample-Not For Sale, 7 Tablets per Carton, 5 mg/500 mg, Rx only, Manufactured By: Bristol-Myers Squibb Company, Princeton NJ 08543, USA, Marketed By: Bristol-Myers Squibb Company, Princeton NJ 08543, USA and AstraZeneca Pharmaceuticals LP, Wilmington DE 19850.
FDA Drug Moderate Oct 31, 2012

Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sample-Not For Sale, 6 Tablets per Carton, 2.5 mg/1000 mg, Rx only, Manufactured By: Bristol-Myers Squibb Company, Princeton NJ 08543, USA, Marketed By: Bristol-Myers Squibb Company, Princeton NJ 08543, USA and AstraZeneca Pharmaceuticals LP, Wilmington DE 19850.
FDA Drug Critical Oct 31, 2012

BiCNU (Carmustine for injection) 100 mg and Diluent Rx Only BiCNU manufactured by: Ben Venue Laboratories, Inc. Bedford, OH 44146 Diluent manufactured by: Luitpold Pharmaceuticals, Inc. Shirley, NY 11967 Distributed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA Made in USA NDC 0015-3012-18 NDC 0015-3012-60

Bristol-Myers Squibb Company is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar drugs volume

Nearest multi-notice firms in the same narrow category lane.

Apace Ky LLC 5 Astellas Pharma US Inc. 5 AstraZeneca Pharmaceuticals LP 5 Atlantic Management Resources Ltd. 5

Frequently Asked Questions

How many federal recall notices name Bristol-Myers Squibb Company? ▼
PlainRecalls indexes 5 distinct federal recall events naming Bristol-Myers Squibb Company, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Bristol-Myers Squibb Company sit among other recalling firms? ▼
Bristol-Myers Squibb Company ranks #2,395 of 14,151 by distinct recall-event count among 14,151 firms in this archive (81st percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Bristol-Myers Squibb Company's notices? ▼
FDA Drug accounts for 5 of this firm's 5 indexed notices.
What product category dominates Bristol-Myers Squibb Company's filing book? ▼
Filings for Bristol-Myers Squibb Company span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Bristol-Myers Squibb Company: 5 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Bristol-Myers Squibb Company; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026